Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.1000 |
Strike | 15.00 |
Expiry date | 2025-01-17 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 334 |
(Bloomberg) -- Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people with knowledge of the matter said. Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisChicago Halts Hiring as Deficit Tops $1 Billion Through 2025After a Record Hot Summer, Pressure Grows for A/C MandatesUC Berkeley Gives Transfer Students a Purpose-Built Home on CampusRome May Start Charging Entry to the Trevi FountainGTCR is seeking t
Key Insights Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their trading...
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.